CN103127508B - 一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 - Google Patents
一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 Download PDFInfo
- Publication number
- CN103127508B CN103127508B CN201310085612.0A CN201310085612A CN103127508B CN 103127508 B CN103127508 B CN 103127508B CN 201310085612 A CN201310085612 A CN 201310085612A CN 103127508 B CN103127508 B CN 103127508B
- Authority
- CN
- China
- Prior art keywords
- herba lycopi
- group
- parts
- days
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 27
- 244000144977 poultry Species 0.000 title claims abstract description 24
- 241000588724 Escherichia coli Species 0.000 title abstract description 21
- 201000010099 disease Diseases 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 title abstract description 5
- 244000144972 livestock Species 0.000 title abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 208000015181 infectious disease Diseases 0.000 claims description 23
- 229940124307 fluoroquinolone Drugs 0.000 claims description 5
- 229960001180 norfloxacin Drugs 0.000 claims description 5
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical group C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims description 3
- 229960003376 levofloxacin Drugs 0.000 claims description 3
- 229950001320 clinafloxacin Drugs 0.000 claims description 2
- QGPKADBNRMWEQR-UHFFFAOYSA-N clinafloxacin Chemical compound C1C(N)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1Cl QGPKADBNRMWEQR-UHFFFAOYSA-N 0.000 claims description 2
- 206010059866 Drug resistance Diseases 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000843 powder Substances 0.000 abstract description 12
- 239000008187 granular material Substances 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 229940124350 antibacterial drug Drugs 0.000 abstract 3
- 241000287828 Gallus gallus Species 0.000 description 37
- 235000013330 chicken meat Nutrition 0.000 description 33
- 239000003814 drug Substances 0.000 description 29
- 229940079593 drug Drugs 0.000 description 22
- 239000004599 antimicrobial Substances 0.000 description 20
- 210000003608 fece Anatomy 0.000 description 20
- 235000013594 poultry meat Nutrition 0.000 description 20
- 241000272525 Anas platyrhynchos Species 0.000 description 16
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 229960003022 amoxicillin Drugs 0.000 description 8
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 8
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 8
- 238000011285 therapeutic regimen Methods 0.000 description 8
- IZJAOWYNDLDRKM-UHFFFAOYSA-N sodium;(4-aminophenyl)sulfonyl-(6-methoxypyrimidin-4-yl)azanide Chemical group [Na+].C1=NC(OC)=CC([N-]S(=O)(=O)C=2C=CC(N)=CC=2)=N1 IZJAOWYNDLDRKM-UHFFFAOYSA-N 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 230000034994 death Effects 0.000 description 5
- 231100000517 death Toxicity 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229960003760 florfenicol Drugs 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 150000003952 β-lactams Chemical class 0.000 description 4
- 241000272522 Anas Species 0.000 description 3
- 208000005156 Dehydration Diseases 0.000 description 3
- 108090000204 Dipeptidase 1 Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 102000006635 beta-lactamase Human genes 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000304886 Bacilli Species 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- ZBHXIWJRIFEVQY-IHMPYVIRSA-N ceftiofur Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 ZBHXIWJRIFEVQY-IHMPYVIRSA-N 0.000 description 2
- 229960005229 ceftiofur Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229940097572 chloromycetin Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000003771 laboratory diagnosis Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- NDIURPSCHWTXDC-UHFFFAOYSA-N 2-(4,5-dimethoxy-2-nitrophenyl)acetohydrazide Chemical compound COC1=CC(CC(=O)NN)=C([N+]([O-])=O)C=C1OC NDIURPSCHWTXDC-UHFFFAOYSA-N 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940038195 amoxicillin / clavulanate Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 229940043312 ampicillin / sulbactam Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000009933 burial Methods 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- NWOYIVRVSJDTLK-YSDBFZIDSA-L disodium;(2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(1r,4s)-3,3-dimethyl-2,2,6-trioxo-2$l^{6}-thiabicyclo[3.2.0]heptane-4-carboxylate Chemical compound [Na+].[Na+].O=S1(=O)C(C)(C)[C@H](C([O-])=O)C2C(=O)C[C@H]21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 NWOYIVRVSJDTLK-YSDBFZIDSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 1
- 229960005256 sulbactam Drugs 0.000 description 1
- 229960000373 tazobactam sodium Drugs 0.000 description 1
- 229940041007 third-generation cephalosporins Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310085612.0A CN103127508B (zh) | 2013-03-18 | 2013-03-18 | 一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310085612.0A CN103127508B (zh) | 2013-03-18 | 2013-03-18 | 一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410165138.7A Division CN103961401A (zh) | 2013-03-18 | 2013-03-18 | 一种含有泽兰和磺胺间甲氧嘧啶钠的畜禽用复方药物 |
CN201410165137.2A Division CN103961400A (zh) | 2013-03-18 | 2013-03-18 | 一种含有泽兰和氟苯尼考的畜禽用复方药物 |
CN201410164413.3A Division CN103948677A (zh) | 2013-03-18 | 2013-03-18 | 一种含有泽兰和阿莫西林的畜禽用复方药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103127508A CN103127508A (zh) | 2013-06-05 |
CN103127508B true CN103127508B (zh) | 2014-08-13 |
Family
ID=48488375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310085612.0A Active CN103127508B (zh) | 2013-03-18 | 2013-03-18 | 一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103127508B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690952B (zh) * | 2013-11-27 | 2016-12-07 | 广西大学 | 治疗畜禽大肠杆菌感染疾病的复方药物 |
CN103933109A (zh) * | 2014-04-15 | 2014-07-23 | 广西大学 | 一种治疗畜禽大肠杆菌感染疾病的方法 |
CN103977088B (zh) * | 2014-05-14 | 2017-01-04 | 广西大学 | 一种含有赤芍和氟喹诺酮类抗菌药的畜禽用复方药物 |
CN103977090B (zh) * | 2014-05-14 | 2016-03-30 | 广西大学 | 一种含有赤芍和氟苯尼考的畜禽用复方药物 |
CN104825524A (zh) * | 2015-01-09 | 2015-08-12 | 广西大学 | 含有三叉风的畜禽用组合物及其制备方法 |
CN104938830A (zh) * | 2015-06-09 | 2015-09-30 | 柳州市明达鸽业养殖专业合作社 | 一种具有防治气囊炎的鸽子喂养用保健砂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101780199B (zh) * | 2010-03-24 | 2011-07-27 | 安徽农业大学 | 用于治疗奶牛乳房炎的中药乳房灌注液及制备方法 |
-
2013
- 2013-03-18 CN CN201310085612.0A patent/CN103127508B/zh active Active
Non-Patent Citations (4)
Title |
---|
16种抗菌药物对大肠杆菌的体外抑菌研究;刘明春等;《东北农业大学学报》;200306;第34卷(第2期);第177页 * |
刘明春等.16种抗菌药物对大肠杆菌的体外抑菌研究.《东北农业大学学报》.2003,第34卷(第2期),第177页. |
梁晓华等.紫茎泽兰提取液的抑菌活性研究.《甘肃农业大学学报》.2010,第45卷(第2期),第116-118页. |
紫茎泽兰提取液的抑菌活性研究;梁晓华等;《甘肃农业大学学报》;201008;第45卷(第2期);第116-118页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103127508A (zh) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127507B (zh) | 一种含有救必应治疗畜禽大肠杆菌感染疾病的复方组合物 | |
CN103690952B (zh) | 治疗畜禽大肠杆菌感染疾病的复方药物 | |
CN103127508B (zh) | 一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 | |
CN103933086A (zh) | 一种含穿心莲和阿米卡星的畜禽用复方药物 | |
CN103961400A (zh) | 一种含有泽兰和氟苯尼考的畜禽用复方药物 | |
CN103948691B (zh) | 一种含有赤芍和磺胺间甲氧嘧啶钠的畜禽用复方药物 | |
CN103301463A (zh) | 一种含有白花丹治疗畜禽大肠杆菌感染疾病的复方组合物 | |
CN103977088A (zh) | 一种含有赤芍和氟喹诺酮类抗菌药的畜禽用复方药物 | |
CN103948656A (zh) | 一种含穿心莲和磷霉素的畜禽用复方药物 | |
CN103948692A (zh) | 一种含有赤芍和阿米卡星的畜禽用复方药物 | |
CN103961401A (zh) | 一种含有泽兰和磺胺间甲氧嘧啶钠的畜禽用复方药物 | |
CN103948677A (zh) | 一种含有泽兰和阿莫西林的畜禽用复方药物 | |
CN104027369A (zh) | 一种含有白花丹和诺氟沙星的畜禽用复方组合物 | |
CN103933544B (zh) | 一种含穿心莲和粘杆菌素的畜禽用复方药物 | |
CN103933543B (zh) | 利用穿心莲和粘杆菌素治疗畜禽大肠杆菌感染疾病的方法 | |
CN103908670B (zh) | 一种治疗畜禽大肠杆菌感染疾病的复方组合物 | |
CN104436160A (zh) | 一种含有大风艾和粘杆菌素的畜禽用复方药物 | |
CN104367601A (zh) | 一种含有凤尾草和痢菌净的畜禽用复方药物 | |
CN104027370A (zh) | 一种含有白花丹和痢菌净的畜禽用复方组合物 | |
CN104435013A (zh) | 一种含有凤尾草和阿米卡星的畜禽用复方药物 | |
CN104435038A (zh) | 一种含有大风艾和痢菌净的畜禽用复方药物 | |
CN104027368A (zh) | 一种含有白花丹和强力霉素的畜禽用复方组合物 | |
CN104042648B (zh) | 一种含有救必应和阿莫西林的畜禽用复方组合物 | |
CN104042651A (zh) | 一种含有救必应和痢菌净的畜禽用复方组合物 | |
CN103933109A (zh) | 一种治疗畜禽大肠杆菌感染疾病的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130605 Assignee: XUZHOU TIANYI ANIMAL PHARMACEUTICAL Co.,Ltd. Assignor: Guangxi University Contract record no.: 2015450000022 Denomination of invention: Herba lycopi containing compound composition for treating escherichia coli infected diseases of livestock and poultry Granted publication date: 20140813 License type: Exclusive License Record date: 20150602 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160513 Address after: 221200 Jiangsu Province, Xuzhou City Ring Road south of Suining County Industrial Park A district (SUI Cheng Zhen Hu Yuan Cun Zhouzhuang group) Patentee after: XUZHOU TIANYI ANIMAL PHARMACEUTICAL Co.,Ltd. Address before: 530004 the Guangxi Zhuang Autonomous Region XiXiangTang Nanning University Road No. 100 Patentee before: Guangxi University |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 221200 A District, South Ring Road Industrial Park, Suining County, Xuzhou, Jiangsu (Zhouzhuang Town, Hu Yuan village, Sui town) Patentee after: XUZHOU TIANYI ANIMAL PHARMACEUTICAL CO.,LTD. Address before: 221200 A District, South Ring Road Industrial Park, Suining County, Xuzhou, Jiangsu (Zhouzhuang Town, Hu Yuan village, Sui town) Patentee before: XUZHOU TIANYI ANIMAL PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 1, Jiuxu Avenue, Suining Economic Development Zone, Xuzhou City, Jiangsu Province, 221200 Patentee after: Xuzhou Tianyi Animal Pharmaceutical Co.,Ltd. Address before: 221200 A District, South Ring Road Industrial Park, Suining County, Xuzhou, Jiangsu (Zhouzhuang Town, Hu Yuan village, Sui town) Patentee before: XUZHOU TIANYI ANIMAL PHARMACEUTICAL CO.,LTD. |